1st Sep 2006 15:19
ReGen Therapeutics PLC01 September 2006 NOTICE OF EGM The Board of ReGen Therapeutics Plc ('ReGen') today announces that anExtraordinary General Meeting ('EGM') of the Company will be convened for 11.00a.m. at the offices of Wilmer Cutler Pickering Hale and Dorr LLP, Alder Castle,10 Noble Street, London EC2V 7QJ on 26 September 2006. The Board announced on 21 July 2006 that the Company had raised gross funds of£1,110,000 through a placing of 111,000,000 new Ordinary Shares. In thisannouncement, ReGen mentioned that depending upon the actual timing ofanticipated revenues from the commercialisation of Colostrinin(TM), theachievement of development milestones and whether other commercial opportunitiespresent themselves, it may be necessary to raise additional amounts of capitalin the future. Accordingly, the Board is seeking to renew Shareholder authorityto be able to issue shares and/or other securities of the Company to facilitatefuture fundraisings (if required) and/or acquisitions of complementarybusinesses. Further information on the proposed resolutions is set out in a circularcontaining the notice of EGM (the 'Circular') which was posted to shareholdersof ReGen today. Copies of the Circular will be available, for collection only, free of charge tothe public, from ReGen, Suite 406, Langham House, 29-30 Margaret Street, LondonW1W 8SA during normal office hours on any day (Saturdays, Sundays excepted) fromtoday until 25 September 2006. For further information please contact: Andrew MarshallGreycoat CommunicationsTel: 020 7960 6007Mobile: 07785 297111 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TILS.L